Search

Learn about Gerstner Sloan Kettering (GSK) student Brian Joseph, who has been awarded the Chairman’s Prize for his paper “Short cryptic exons mediate recursive splicing in drosophila.”

… Wednesday, October 31, 2018 Gerstner Sloan Kettering (GSK) student Brian Joseph has been awarded the Chairman’s Prize for his paper “ Short cryptic exons mediate recursive splicing in drosophila ,” published in Nature Structural and Molecular Biology in April 2018. His work sheds light on the mechanism

The Caring Canines program at Memorial Sloan Kettering has been going strong for more than 12 years.

… Thursday, April 30, 2020 Summary Therapy dogs do more than put smiles on the faces of people with cancer — they may actually help some people heal. Editor’s note: During the COVID-19 pandemic, Memorial Sloan Kettering’s Caring Canines therapy dog program is largely on hold. However, we are providing

The Ralph Lauren Center for Cancer Care, a Harlem-based cancer prevention and treatment program, is expected to more closely align with Memorial Sloan Kettering Cancer Center (MSK) in 2019 pending the approval of the New York State Department of Health and other state agencies. The filing deepens the longstanding partnership between MSK and the Ralph Lauren Center. 

… Tuesday, August 7, 2018 The Ralph Lauren Center for Cancer Care , a Harlem-based cancer prevention and treatment program, is expected to more closely align with Memorial Sloan Kettering Cancer Center (MSK) in 2019 pending the approval of the New York State Department of Health and other state agencies

Germline and somatic oncogenic alterations are frequently seen in breast cancer, yet it’s not well understood how their interaction influences tumor evolution and therapy resistance. Researchers now have new insights through a comprehensive integrated clinicogenomic analysis and preclinical investigation led by Memorial Sloan Kettering Cancer Center.

… Wednesday, March 4, 2026 Germline and somatic oncogenic alterations are frequently seen in breast cancer, yet it’s not well understood how their interaction influences tumor evolution and therapy resistance. Researchers now have new insights through a comprehensive integrated clinicogenomic analysis

Meet three creative arts therapists at Memorial Sloan Kettering.

… Thursday, April 5, 2018 Summary The path to feeling better goes far beyond conventional medicine. Creative arts therapists at Memorial Sloan Kettering help people with cancer craft meaning out of their experiences. Art has a proven, powerful effect on the healing process. At Memorial Sloan Kettering,

Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.

… Monday, December 1, 2008 Summary Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential. The strategy of using monoclonal antibodies for cancer treatment was first described in the late 1970s with the promise that they could be developed

MSK radiation therapy experts set the record straight about the safety of this effective treatment.

… Thursday, May 28, 2020 Summary Memorial Sloan Kettering experts answer common questions about the safety of adults undergoing  radiation treatment for cancer . Radiation treatment is one of the most common and effective ways to destroy cancer cells and shrink tumors. At Memorial Sloan Kettering, approximately

Dr. Brown, whose research has been shedding light on the development of the early life immune system and its relationship to autoimmunity, allergy, inflammation and cancer, was among 30 early career scientists nationwide selected for the 2025 class of scholars.

… Wednesday, October 1, 2025 Immunologist Chrysothemis Brown, MD, PhD , whose research has been shedding light on the development of the early life immune system and its relationship to autoimmunity, allergy, inflammation, and cancer, was among 30 early-career scientists nationwide selected for the 2025

Learn about some of the most important advances in cancer treatment at MSK in 2025.

… Monday, December 15, 2025 Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in a variety of cancer treatments in 2025 — including new approaches to immunotherapy, targeted therapy, and surgical imaging. Highlights this year also included a stem cell–based therapy for Parkinson

New research from Sloan Kettering Institute investigators pinpoints altered cell metabolism as a cause of B cell lymphoma.

… Monday, June 22, 2020 Summary Scientists at the Sloan Kettering Institute have found that increased activity of a normal metabolic enzyme can lead to cancer. The enzyme, SHMT2, is a driver of a large portion of B cell lymphomas and could be a potential drug target. Because of how aggressively they divide